Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $30
Benzinga Newsdesk 1 year ago
NewsPrice TargetSmall CapAnalyst Ratings
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE: GRDN) with a Buy and raises the price target from $28 to $30.
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE: GRDN) with a Buy and raises the price target from $28 to $30.